GoKawiilMusk-Linked SpaceX and Tesla Directors Fund Push for MDMA Therapy Approval
Several board members from Elon Musk's companies, including SpaceX and Tesla, are directing personal funding toward psychedelic research and a startup pursuing regulatory approval for MDMA-assisted therapy. The investments span both academic studies and commercial drug-development efforts aimed at treating conditions like PTSD.
GoKawiil's interpretation of the reporting above, not reported fact.
Backing from figures tied to major tech firms could accelerate mainstream acceptance and funding for psychedelic medicine, which has struggled with stigma and slow regulatory pathways. Their involvement may also bring Silicon Valley's risk tolerance and networking power to a field historically underfunded by traditional pharma investors.
- Musk-affiliated directors are funding both academic and commercial psychedelic research.
- MDMA-assisted therapy is a key focus, aimed at regulatory approval.
- Tech-industry money could speed mainstream adoption of psychedelic treatments.
Source: wsj.com, 2026-09-05
Published there as: “Elon Musk’s Inner Circle Is Pouring Cash Into Making Psychedelics Mainstream”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.